Back

In vitro characterization of a novel PI 3-kinase inhibitor for growth factor-induced effects in pulmonary artery smooth muscle cells

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Vascular signalling Hypertension, Pulmonary Hypertension ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Eva Berghausen

University of Cologne, Cologne (Germany)

6 More presentations in this session

Presentation thumbnail
Selective inhibition of the Mek1/2-Erk1/2 signalling pathway induces the differentiation of human cardiac pericyte-like cells into contractile vascular smooth muscle cells
Doctor E. Avolio (Bristol, GB)
Abstract
Presentation thumbnail
Deficiency of PI 3-kinase isoform p110alpha in smooth muscle cells impairs vascular integrity and promotes aortic aneurysm formation
Doctor M. Vantler (Cologne, DE)
Abstract
Presentation thumbnail
Tumor necrosis factor receptor-associated factor 5 (TRAF-5) deficiency exacerbates diet-induced adipose tissue inflammation and aggravates metabolic syndrome in mice
Mr M. Gissler (Freiburg, DE)
Abstract
Presentation thumbnail
Reciprocal regulation of Endothelial-Mesenchymal Transition by MAPK7 and EZH2 activity in Intimal Hyperplasia and Coronary Artery Disease
Doctor B. Vanchin (Ulaanbaatar, MN)
Abstract
Presentation thumbnail
The nuclear receptor corepressor 1 blocks CD36-mediated foam cell formation in atherogenesis
Miss S. Oppi (Schlieren, CH)
Abstract

Access the full session

Session thumbnail
Vascular signalling

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources